Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Recent Health Care Deals, week ending November 6, 2015
AcquirerTargetPrice Shire plcDyax Corp.$5.9 billion Bristol-Myers SquibbCardiopxyl Pharmaceuticals$300 million Pamplona Capital ManagementMedAssets, Inc. $2.7 billion Envison Healthcare HoldingsQuestcare Medical Services$135 million Sheridan HealthcareValley Anesthesiology & Pain... Read More »Physician Practices Make Big Targets
The acquisitions continue in the Physician Medical Group sector. Through the first week of November, we’ve recorded 64 transactions targeting physician practices, up 6.7% over 2014’s total of 60 deals. Spending in 2015 is trailing slightly. At $2.2 billion, it’s off 30% from the full-year total of nearly $3.2 billion in 2014. Check out the chart below. 2015, thru Nov. 720142013 201220112010 Deal volume6460657011567 % change6.7%-7.7%-7.1%-39.1%71.6%63.4% Deal value$2.235 billion$3.181 billion$583 million$4.411 billion$446 million$425 million % change-29.7%445.5%-86.8%888.0%5.0%329.3% Source: Health Care M&A News, November 9,... Read More »Allergan Licenses Dry Eye Treatment
Allergan plc (NYSE: AGN) is making inroads in the dry eye disease treatment area, paying $50 million upfront to license Mimetogen Pharmaceuticals’ tavilermide (MIM-D3), a topical formulation of a novel small molecule TrkA agonist. Allergan will also fund Phase 3 development of the drug, which has shown the ability to improve patient-reported blurriness and poor vision. The deal bolsters Allergan’s mid- to late-stage pipeline in eye care products. Read More »MedAssets Acquired and Split Up
Pamplona Capital Management, a New York-based investment group, announced its acquisition of MedAssets, Inc. (NASDAQ: MDAS) for $2.7 billion. MedAssets provides technology-enabled products and services for hospitals, health systems, non-acute healthcare providers, payers and other service providers. The price of $2.7 billion represents $31.35 per share. Pamplona already has an agreement in place to divest MedAssets’ Spend and Clinical Resource Management segment to VHA-UHC Alliance for an undisclosed price. VHA and UHC merged earlier this year to form the largest member-owned health care company in the United States. That leaves Pamplona Capital with MedAssets’ Revenue Cycle... Read More »Big Deal of the Day: Shire Buys Dyax
Shire plc (NASDAQ: SHPG) is on a buying binge in 2015. After agreeing to be acquired by AbbVie (NYSE: ABBV) for $54.7 billion in July 2014, the deal fell apart in October following the Treasury Department’s revised ruling on foreign domiciles. Shire management turned around and acquired rare disease drug maker NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) in January for $5.2 billion, then added prescription drug maker Meritage Pharma, Inc. in February for $70 million. After a few months digesting those deals, Shire was back on the acquisition trail in August, paying $300 million for Foresight Biotherapeutics Inc., a clincal stage drug development company. Now it’s agreed to pay... Read More »Recent Health Care Deals, week ending 10.30.15
AcquirerTargetPrice Vertex PharmaceuticalsCollaboration on gene editing technology$105 million SinocareNipro Diagnostics$273 million Ortho Rhode Island3 orthopedic practicesMerger Omnicell, Inc. Aesynt$275 million Chartwell Retirement Residences5 retirement communities$192.9... Read More »Pharma Automation Company Gets $275 Million
Omnicell, Inc. (NASDAQ: OMCL), which provides automation and business analytics solutions for medication and supply management, paid $275 million for Aesynt, a portfolio company of Francisco Partners. Aesynt, which Francisco only acquired in 2013, brings distinct capacities in dispensing systems, central pharmacy robotics, IV robotics and analytics. Aesynt’s robust medication management tools will complement Omnicell’s product portfolio and international footprint. Read More »Aurora Diagnostics Adds More Labs
Independent laboratory company Aurora Diagnostics made its first announced acquisition in 2015, paying an undisclosed amount for Consultants in Laboratory Medicine of Greater Toledo, Inc. The target is a hospital-based practice providing anatomic laboratory medicine professional pathology services to 11 hospitals in Michigan and Ohio. Aurora Diagnostics focuses on anatomic pathology and now has 25 locations in the United States. Last year it acquired four pathology lab companies: West Georgia Pathology, LLC; Arizona Dermatopathology; Hallmark Pathology, PC and Mid-Atlantic Pathology Services, Inc. Obviously it took a while to digest those acquisitions. Read More »Q3:15 Health Care Dollars, vs. Q2:15
Last week we gave you the breakdown on how the third quarter of 2015 compared with the second quarter and the same quarter a year ago. Here’s how the dollars broke out, versus those quarters. SectorQ3:15Q2:15ChangeQ3:14Change Services Behavioral Health Care$550,000$190,700188%$335,00064% Home Health & Hospice$241,854$0n/a$410,000-41% Hospitals$2,069,865 $2,059,9000.5%$969,800113% Labs, MRI & Dialysis$826,600$1,507,650-45%$324,000155% Long-Term Care$4,175,656$4,141,9300.8%$9,686,200-57% Managed Care$98,000,000$147,00066566%$0n/a Physician Medical Groups$1,600,000$500,000220%$0n/a Rehabilitation $4,300$734,800-99%$163,450-97% Other Services$1,396,474$16,211,644-91%$1,026,40036%... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
